Wu Tsai Human Performance Alliance
Showing 11-20 of 205 Results
Annelise E. Barron
Associate Professor of Bioengineering
Current Research and Scholarly InterestsBiophysical mechanisms of host defense peptides (a.k.a. antimicrobial peptides) and their peptoid mimics; also, molecular and cellular biophysics of human innate immune responses.
Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology
BioProfessor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.
Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.
Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.
The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.
Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly.
Achintya K. Bhowmik, PhD
Adjunct Professor, OHNS/Otology & Neurotology Division
BioDr. Achin Bhowmik serves on the faculty of Stanford University as an adjunct professor at the Stanford School of Medicine, where he advises research and lectures in the areas of sensory augmentation, computational perception, cognitive neuroscience, and intelligent systems. He is also an affiliate faculty member of the Stanford Institute for Human-Centered Artificial Intelligence, Wu Tsai Neurosciences Institute and Human Performance Alliance, and a mentor for the Stanford Institutes of Medicine Summer Research Program.
He is the chief technology officer and executive vice president of engineering at Starkey Hearing Technologies, a privately-held medical devices company with over 5,000 employees and operations in over 100 countries worldwide. In this role, he is responsible for the company’s technology strategy, research and development, engineering and program management departments, and leading the drive to transform hearing aids into multifunction wearable health and communication devices with advanced sensors and artificial intelligence.
Previously, Dr. Bhowmik was the vice president and general manager of the Perceptual Computing Group at Intel Corporation, where he was responsible for the R&D, engineering, operations, and businesses in the areas of 3D sensing and interactive computing, computer vision and artificial intelligence, autonomous robots and drones, and immersive virtual and merged reality devices.
Dr. Bhowmik is a member of the Forbes Technology Council, board of trustees for the National Captioning Institute, board of directors for OpenCV, board of advisors for the Fung Institute for Engineering Leadership at the University of California, Berkeley, and industry advisory board for the Institute for Engineering in Medicine and Biomedical Engineering at the University of Minnesota. He is also on the board of directors and advisors for several technology startup companies.
He has also held adjunct and guest professor positions at the University of California, Berkeley, Liquid Crystal Institute of the Kent State University, Kyung Hee University, Seoul, and the Indian Institute of Technology, Gandhinagar. He received his Bachelor of Technology from the Indian Institute of Technology, Kanpur, PhD from Auburn University, and attended the Executive Program at Stanford University. He has authored over 200 publications, including two books and over 80 granted patents.
His awards and honors include Fellow of the Institute of Electrical and Electronics Engineers (IEEE), Fellow of the Asia-Pacific Artificial Intelligence Association (AAIA), President and Fellow of the Society for Information Display (SID), Top 25 Healthcare Technology CTOs by the Healthcare Technology Report, Notable Leaders in Healthcare by Twin Cities Business, Healthcare Heroes award from the Business Journals, Industrial Distinguished Leader award from the Asia-Pacific Signal and Information Processing Association, IEEE Distinguished Industry Speaker, TIME’s Best Inventions, Red Dot Design award, MUSE Design award, and the Artificial Intelligence Excellence award.
Dr. Bhowmik and his work have been covered in numerous press articles, including TIME, Fortune, Wired, USA Today, US News & World Reports, Wall Street Journal, CBS News, BBC, Forbes, Bloomberg Businessweek, Scientific American, Popular Mechanics, MIT Technology Review, EE Times, The Verge, etc.
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
UPS Foundation Professor and Senior Fellow at the Woods Institute for the Environment
BioOur group studies the impact of building design, materials, and symbols on human wellbeing including stress, physical activity, creativity, sense of belonging, and pro-environmental behavior. We are exploring how buildings can include both physical and digital adaptations to improve wellbeing outcomes including new methods of bringing nature and the experience of nature into buildings. We are interested in how building management systems can be extended beyond providing energy savings, thermal comfort, and security to support and maintain a broader set of human wellbeing outcomes while preserving occupant privacy. Further, we are studying the impact of built features, including historic structures, on community wellbeing and methods of design for community wellbeing that support the equitable development of affordable and permanent supportive housing.
Our group also has a long history of expertise in the design and evaluation of sustainable, durable construction materials, their application to structures and construction, including damage-tolerant, high-performance fiber-reinforced cementitious composite materials, and bio-based fiber-reinforced polymeric composites and insulating foams that have a closed loop life-cycle.
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
Charles and Elizabeth Prothro Professor of Marine Sciences, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsThermal physiology, open ocean predators, ecological physiology and tuna biology
Stephen Harris Professor and Professor of Materials Science and Engineering and, by courtesy, of Applied PhysicsOn Partial Leave from 01/01/2023 To 03/31/2023
BioMark Brongersma is a Professor in the Department of Materials Science and Engineering at Stanford University. He received his PhD in Materials Science from the FOM Institute in Amsterdam, The Netherlands, in 1998. From 1998-2001 he was a postdoctoral research fellow at the California Institute of Technology. During this time, he coined the term “Plasmonics” for a new device technology that exploits the unique optical properties of nanoscale metallic structures to route and manipulate light at the nanoscale. His current research is directed towards the development and physical analysis of nanostructured materials that find application in nanoscale electronic and photonic devices. Brongersma received a National Science Foundation Career Award, the Walter J. Gores Award for Excellence in Teaching, the International Raymond and Beverly Sackler Prize in the Physical Sciences (Physics) for his work on plasmonics, and is a Fellow of the Optical Society of America, the SPIE, and the American Physical Society.